128 related articles for article (PubMed ID: 18436148)
21. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke.
Angeli F; Gentile G; Reboldi G; Verdecchia P
Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1171-4. PubMed ID: 18939903
[No Abstract] [Full Text] [Related]
22. Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain.
Miyamoto N; Zhang N; Tanaka R; Liu M; Hattori N; Urabe T
Neurosci Res; 2008 Jul; 61(3):249-56. PubMed ID: 18455256
[TBL] [Abstract][Full Text] [Related]
23. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Qian C; Schoemaker RG; van Gilst WH; Roks AJ
Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
Sakairi A; Ishida J; Honjo K; Inaba S; Nakamura S; Sugiyama F; Yagami K; Fukamizu A
Hypertens Res; 2008 Dec; 31(12):2165-75. PubMed ID: 19139606
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
Dowlatshahi D; Hill MD
Expert Rev Cardiovasc Ther; 2009 May; 7(5):459-64. PubMed ID: 19419253
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
27. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
28. [Endothelium-protective effects of vinpocetine, pentoxifylline and enalapril in patients with chronic brain ischemia].
Vaizova OE; Vengerovsky AI; Alifirova VM
Eksp Klin Farmakol; 2011; 74(4):10-3. PubMed ID: 21678652
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
30. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model.
Wang L; Cai SR; Zhang CH; He YL; Zhan WH; Wu H; Peng JJ
Chin Med J (Engl); 2008 Nov; 121(21):2167-71. PubMed ID: 19080179
[TBL] [Abstract][Full Text] [Related]
31. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Pimenta E; Oparil S
Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229
[TBL] [Abstract][Full Text] [Related]
32. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
[TBL] [Abstract][Full Text] [Related]
33. Cerebral microvessel responses to focal ischemia.
del Zoppo GJ; Mabuchi T
J Cereb Blood Flow Metab; 2003 Aug; 23(8):879-94. PubMed ID: 12902832
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
Armario P; de la Sierra A
Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):197-204. PubMed ID: 19443514
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin converting enzyme inhibition and cerebral circulation--a review.
Waldemar G; Paulson OB
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):177S-182S. PubMed ID: 2690908
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
Bose SK; Gibson W; Giri S; Nath N; Donald CD
Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
[TBL] [Abstract][Full Text] [Related]
37. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
Lim S
Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia.
Spudich A; Kilic E; Xing H; Kilic U; Rentsch KM; Wunderli-Allenspach H; Bassetti CL; Hermann DM
Nat Neurosci; 2006 Apr; 9(4):487-8. PubMed ID: 16565717
[TBL] [Abstract][Full Text] [Related]
39. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.
Saavedra JM; Sánchez-Lemus E; Benicky J
Psychoneuroendocrinology; 2011 Jan; 36(1):1-18. PubMed ID: 21035950
[TBL] [Abstract][Full Text] [Related]
40. Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor?
van Esch JH; Oosterveer CR; Batenburg WW; van Veghel R; Jan Danser AH
Eur J Pharmacol; 2008 Jul; 588(2-3):286-93. PubMed ID: 18511032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
